Vitamin D Levels And Myoma Uteri
Vitamin D Levels İn Women With and Without Myoma Uteri
1 other identifier
observational
300
1 country
1
Brief Summary
Women with at least one uterine leiomyoma and polycystic ovary syndrome over 10 mm and women with normal ultrasonographic findings were included in the study. Blood samples were taken for biochemical analysis such as vitamin D, calcium, magnesium, phosphorus, thyroid stimulating hormone (TSH), hemoglobin (hb), hematocrit (htc), platelet (plt), and albumin. The study groups were compared in terms of these biochemical markers and family history of patients, daily sunshine hours, clothing preferences and education level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2019
CompletedFirst Submitted
Initial submission to the registry
March 11, 2019
CompletedFirst Posted
Study publicly available on registry
March 12, 2019
CompletedMarch 14, 2019
March 1, 2019
3 months
March 11, 2019
March 12, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vitamin D levels
Vitamin D levels in blood test
december 2018- march 2019
Study Arms (2)
study group
In Woman With Myoma Uteri
control group
In Woman Without Myoma Uteri
Eligibility Criteria
The reproductive age women (25-50 years) with at least one 10 mm or larger diameter leiomyoma detected by transvaginal ultrasound were the study group.
You may not qualify if:
- Patients with a history of myomectomy,
- chronic systemic disease
- malignancy
- history of adenomyosis
- women in menopause
- pregnant women
- vitamin D supplementation
- lactation
- abortion and pregnancy loss in the last 6 months
- oral contraceptive / hormonal agents in the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, 33403, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- pınar kadiroğulları M.D, Department of Obstetrics and Gynecology
Study Record Dates
First Submitted
March 11, 2019
First Posted
March 12, 2019
Study Start
December 1, 2018
Primary Completion
March 1, 2019
Study Completion
March 1, 2019
Last Updated
March 14, 2019
Record last verified: 2019-03